Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

M. J. Wensing, Annemarie; van de Vijver, David; Angarano, Gioacchino; Åsjö, Birgitta; Balotta, Claudia; Boeri, Enzo; Camacho, Ricardo; Chaix, Maire‐Laure; Costagliola, Dominique; De Luca, Andrea; Derdelinckx, Inge; Grossman, Zehava; Hamouda, Osamah; Hatzakis, Angelos; Hemmer, R; I. M. Hoepelman, Andy; Horban, Andrzej; Korn, Klaus; Kücherer, Claudia; Leitner, Thomas; Loveday, Clive; MacRae, E; Maljkovic, Irina; de Mendoza, Carmen; Meyer, Laurence; Nielsen, Claus; LM Op de Coul, Eline; Ormaasen, Vidar; Paraskevis, Dimitris; Perrin, Luc; Puchhammer‐Stöckl, Elisabeth; Ruiz, Lı́dia; Salminen, Mika; Schmit, Jean‐Claude; Schneider, F; Schuurman, Rob; Soriano, Vincent; Stanczak, G; Stanojević, Maja; Vandamme, Anne‐Mieke; Van Laethem, Kristel; Violin, Michela; Wilbe, Karin; Yerly, Sabine; Zazzi, Maurizio; A. Boucher, Charles; Programme, SPREAD

doi:10.1086/432916

Public

Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Published in The Journal of Infectious Diseases • Aug 19, 2005

Authors:

Annemarie M. J. Wensing

David van de Vijver

Gioacchino Angarano

Abstract

BACKGROUND: Infection with drug-resistant human immunodeficiency virus type 1 (HIV-1) can impair the response to combination therapy. Widespread transmission of drug-resistant variants has the disturbing potential of limiting future therapy options and affecting the efficacy of postexposure prophyla...

Subject

Drug resistance

Medicine

Resistance mutation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!